Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent

Cimetidine, the first H(2) receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct me...

Full description

Saved in:
Bibliographic Details
Published in:Ecancermedicalscience
Main Authors: Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P
Format: Artigo
Language:Inglês
Published: Cancer Intelligence 2014
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268104/
https://ncbi.nlm.nih.gov/pubmed/25525463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2014.485
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items